Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Dec 07, 2022 1:23pm
294 Views
Post# 35156810

RE:RE:RE:RE:RE:RE:RE:RE:2 weeks: It’s all it took for Merck to get AA

RE:RE:RE:RE:RE:RE:RE:RE:2 weeks: It’s all it took for Merck to get AAThanks Eoganacht interesting is that figure represents the Canadian and US markets while clinical trials are being done in each country, Europe was originally going to be included was dropped because of a higher cost. Worldwide NMIBC cases comes in at an estimated 573,000 which would put the North American percentage at 17% of new world cases. I don't know how long it takes ( months or years ) to be given a green light in various world countries.  Add in world countries treating people undergoing accepted treatments that would migrate to Theralase's treatment then we are talking a much larger market than new cases, big bucks wanting to get off the current continuous treadmill. 
<< Previous
Bullboard Posts
Next >>